Analysis of the domestic market of medicines used for the symptomatic treatment of cough
DOI:
https://doi.org/10.24959/sphhcj.21.236Keywords:
market analysis; medicines, pharmaceutical market of Ukraine; cough treatment; assortment.Abstract
To study of the range of medicines for the symptomatic treatment of cough at the pharmaceutical market of Ukraine.
References
- References
- Zaitsev, A. A. (2018). Mucoactive cough therapy: what is behind the horizon? Lechaschi Vrach, 10, 22–27.
- Zaitsev, A. A., Okovityi, S. V., Kriukov, E. V. (2015). Kashel. Prakticheskoe posobie dlia vrachei. Moscow: GVKG im. N. N. Burdenko, 59.
- Chernykh, V. P., Zupanets, I. A., Kupnovytska, I. H. et al. (Eds.). (2013). Oryhinalni ta henerychni likarski preparaty. Samolikuvannia y farmatsevtychna opika. Klinichna farmatsiia. Kharkiv: NFaU: Zoloti storinky, 911.
- Finley, C. R., Chan, D. S., Garrison, S., Korownyk, Ch., Kolber, M. R., Campbell, S., Eurich, D. T. et al. (2018). What are the most common conditions in primary care? Systematic review. Canadian Family Physician, 64 (11), 832–840.
- Balbani, А. Р. S. (2012). Cough: neurophysiology, methods of research, pharmacological therapy and phonoaudiology. International archives of otorhinolaryngology, 16 (2), 259–268. doi: https://doi.org/10.7162/S1809-97772012000200016.
- MOZ Ukrainy. (2019). Nakaz vid 05.06.2019 No. 1269 “Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry kashli”. moz.gov.ua. Available at: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-05062019--1269-pro-zatverdzhennja-ta-vprovadzhennja-mediko-tehnologichnih-dokumentiv-zi-standartizacii-ekstrenoi-medichnoi-dopomogi.
- MOZ Ukrainy. (2015). Nakaz vid 08.06.2015 No. 327 “Unifikovanyi klinichnyi protokol pervynnoi medychnoi dopomohy. Kashel u doroslykh”. dec.gov.ua. Available at: https://www.dec.gov.ua/wp-content/uploads/2019/11/2015_327ykpmd_kashel_dor.pdf.
- Asthma Workgroup, Chinese Society, Respiratory, Diseases (CSRD), Chinese Medical Association. (2011). The Chinese national guidelines on diagnosis and management of cough. Chinese Medical J., 124 (20), 3207–3219. Available at: https://pubmed.ncbi.nlm.nih.gov/22088510/.
- Morice, A. (2002). Epidemiology of cough. Pulmonary Pharmacology and Therapeutics, 15 (3), 253–259. doi: https://doi.org/10.1006/pupt.2002.0352.
- Khimion, L. V., Yashchenko, O. B., Danyliuk, S. V., Sytiuk, T. O. (2016). Symptomatic treatment of cough in adults. Zdorov’ia Ukrainy 21 storichchia, 1 (374), 3–5. Available at: https://health-ua.com/wp-content/uploads/2016/03/3-5.pdf.
- Aptechna Profesiina Asotsiatsiia Ukrainy. (2019). Na dopomohu farmatsevtu: suchasni aspekty likuvannia kashliu u ditei. apau.org.ua. Available at: https://apau.org.ua/2019/02/07/.
- Chulovska, U. B. (2021). Zdorov’ia Ukrainy 21 storichchia, 10 (503), 52–54. Available at: https://health-ua.com/article/66171-suchasn-strateg-lkuvannya-kashlyu-vterapevtichnj-praktitc.
- Koskela, H. O., Lätti, A. M., Pekkanen, J. (2018). The impacts of cough : a cross-sectional study in a Finnish adult employee population. ERJ Open Research, 12 (4), 00113-2018. doi: 10.1183/23120541.00113-2018.
- Derzhavnyi reiestr likarskykh zasobiv Ukrainy. Available at: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument&atscode=R05.
- Kovalenko, V. M. (Ed.). (2019). Compendium 2019 – drugs. Kyiv: MORION, 2480.
- Onyshkiv, O. I., Lekh, I. P., Hroshovyi, T. A. (2015). Pharmaceutical Journal, 1, 71–75.
- Kukhtenko, O. S., Hladukh, E. V., Simonian, L. S. (2017). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 4 (52), 42–49. doi: https://doi.org/10.24959/uekj.17.35.
Downloads
Published
2021-12-24
How to Cite
Analysis of the domestic market of medicines used for the symptomatic treatment of cough. (2021). Social Pharmacy in Health Care, 7(4), 61–69. https://doi.org/10.24959/sphhcj.21.236
Issue
Section
Social marketing and pharmacoeconomic research
License
Copyright (c) 2021 National University of Pharmacy

This work is licensed under a Creative Commons Attribution 4.0 International License.





